[{"address1": "The SchrOedinger Building", "address2": "Oxford Science Park", "city": "Oxford", "zip": "OX4 4GE", "country": "United Kingdom", "phone": "44 18 6581 8941", "website": "https://www.exscientia.ai", "industry": "Biotechnology", "sector": "Healthcare", "longBusinessSummary": "Exscientia plc, an artificial intelligence-driven pharmatech company, engages in discovering, designing, and developing drugs. The company offers end-to-end solution of artificial intelligence (AI) and technologies for target identification, drug candidate design, translational models, and patient selection. It also focuses on discovery and development of small molecule drug candidates. The company's platform enables to design candidate drug molecules, as well as to provide patients with drug therapies through AI guided assessment. Exscientia plc was founded in 2012 and is headquartered in Oxford, the United Kingdom.", "fullTimeEmployees": 481, "companyOfficers": [{"maxAge": 1, "name": "Mr. Ben R. Taylor", "age": 46, "title": "CFO, Chief Strategy Officer & Executive Director", "yearBorn": 1977, "fiscalYear": 2022, "totalPay": 484597, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Michael  Krams M.D.", "age": 62, "title": "Chief Quantitative Medicine Officer", "yearBorn": 1961, "fiscalYear": 2022, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Eileen  Jennings-Brown", "title": "Chief Information Officer", "fiscalYear": 2022, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Sara  Sherman", "title": "Vice President of Investor Relations", "fiscalYear": 2022, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Dan  Ireland", "title": "Vice President of Legal & Company Secretary", "fiscalYear": 2022, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Parker  Moss", "title": "Executive Vice President of Corporate Development", "fiscalYear": 2022, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Caroline  Rowland", "title": "Chief People Officer", "fiscalYear": 2022, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Richard  Law", "title": "Chief Business Officer", "fiscalYear": 2022, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. John P. Overington Ph.D.", "title": "Chief Data Officer", "fiscalYear": 2022, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Nikolaus  Krall", "title": "Executive Vice President of Precision Medicine", "fiscalYear": 2022, "exercisedValue": 0, "unexercisedValue": 0}], "compensationAsOfEpochDate": 1672444800, "maxAge": 86400, "priceHint": 2, "previousClose": 5.42, "open": 5.35, "dayLow": 5.3, "dayHigh": 5.69, "regularMarketPreviousClose": 5.42, "regularMarketOpen": 5.35, "regularMarketDayLow": 5.3, "regularMarketDayHigh": 5.69, "beta": 0.827, "forwardPE": -3.9635036, "volume": 456346, "regularMarketVolume": 456346, "averageVolume": 693728, "averageVolume10days": 624800, "averageDailyVolume10Day": 624800, "bidSize": 1000, "askSize": 800, "marketCap": 678424192, "fiftyTwoWeekLow": 4.17, "fiftyTwoWeekHigh": 9.12, "priceToSalesTrailing12Months": 27.733799, "fiftyDayAverage": 6.3045, "twoHundredDayAverage": 6.263175, "currency": "USD", "enterpriseValue": 330112480, "floatShares": 91499579, "sharesOutstanding": 124940000, "sharesShort": 3773467, "sharesShortPriorMonth": 2791451, "sharesShortPreviousMonthDate": 1705017600, "dateShortInterest": 1707955200, "sharesPercentSharesOut": 0.030199999, "heldPercentInsiders": 0.26903, "heldPercentInstitutions": 0.25618, "shortRatio": 4.85, "shortPercentOfFloat": 0.063200004, "bookValue": 3.145, "priceToBook": 1.72655, "lastFiscalYearEnd": 1672444800, "nextFiscalYearEnd": 1703980800, "mostRecentQuarter": 1696032000, "netIncomeToCommon": -143912000, "trailingEps": -1.49, "forwardEps": -1.37, "pegRatio": 0.08, "enterpriseToRevenue": 13.495, "enterpriseToEbitda": -1.995, "exchange": "NMS", "quoteType": "EQUITY", "symbol": "EXAI", "underlyingSymbol": "EXAI", "shortName": "Exscientia Plc", "longName": "Exscientia plc", "firstTradeDateEpochUtc": 1633095000, "timeZoneFullName": "America/New_York", "timeZoneShortName": "EST", "uuid": "338b7c25-91d3-36d5-9c38-0f21999063b2", "gmtOffSetMilliseconds": -18000000, "currentPrice": 5.43, "targetHighPrice": 10.0, "targetLowPrice": 7.0, "targetMeanPrice": 8.67, "targetMedianPrice": 9.0, "recommendationMean": 2.7, "recommendationKey": "hold", "numberOfAnalystOpinions": 3, "totalCash": 366612000, "totalCashPerShare": 2.934, "ebitda": -165432992, "totalDebt": 18302000, "quickRatio": 6.585, "currentRatio": 6.675, "totalRevenue": 24462000, "debtToEquity": 4.657, "revenuePerShare": 0.198, "returnOnAssets": -0.17990999, "returnOnEquity": -0.31839, "freeCashflow": -154456256, "operatingCashflow": -165870000, "revenueGrowth": 0.41, "grossMargins": -0.26744, "operatingMargins": -4.559, "financialCurrency": "GBP", "trailingPegRatio": null}]